Form 4: Charles River Laboratories Director George Massaro Sells Shares Under 10b5-1 Plan

Director George Massaro of Charles River Laboratories sold a portion of his common stock holdings on May 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 15, 2024, George Massaro, a director at Charles River Laboratories International, Inc., sold shares of common stock.
• The sales were executed in multiple transactions at varying prices.
• A total of 123 shares were sold at a weighted average price of $234.72.
• An additional 113 shares were sold at a weighted average price of $235.61.
• Finally, 96 shares were sold at a weighted average price of $236.78.
• These transactions were conducted under a pre-existing 10b5-1 trading plan.
• Following these transactions, Massaro directly owns 5,855 shares of Charles River Laboratories common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions.

Industry Context

Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific inside information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates